8-K - Allarity Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. Equity Line of Credit Common Stock Purchase Agreement On January 28, 2026, Allarity Therapeutics, Inc. (the “ Compan

Material Agreement

$6.0M$1.0M

Source Document

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1* Common Stock Purchase Agreement, dated as of January 28, 2026, by and betwee

Exhibits Only

Exhibits (2)

10.1

COMMON STOCK PURCHASE AGREEMENT, DATED AS OF JANUARY 28, 2026, BY AND BETWEEN THE COMPANY AND TUMIM STONE CAPITAL, LLC

8-K

CURRENT REPORT